BioSpace News Archive

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing onvansertib to treat cancers with the greatest medical needs for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer and castrate-resistant prostate cancer, today announced that Dr. Mark Erlander,

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the U.S. Food and Drug Administration (US FDA) has provided details of the additional information it is requesting regarding its Chimeric Antigen Receptor-T cell therapy

Shuttle Pharmaceuticals Holdings, Inc., (Shuttle Pharma) a clinical stage company developing drugs to improve the treatment of cancer patients undergoing radiation therapy is pleased to announce the addition of Chris Senanayake , PhD as a member of its Board of Directors.

At a crucial time when vaccination against potentially deadly diseases is top of mind, the National Meningitis Association is teaming up with award-winning actress, author and mother of three Molly Ringwald to encourage parents to talk to their teen’s doctor about the potentially life-saving second dose of the MenACWY vaccine for meningococcal disease.5

ImmunoPrecise Moves SARS-CoV-2 PolyTope ™ Cocktail Program’s Path Toward IND Filing - Demonstrating what the Company believes to be the first reported in vivo synergistic effects of a multi-antibody (3+) combination treatment - Dr. Ilse Roodink and Dr. Debby Kruijsen to host live webinar “Function First: Using complementary antibody platforms to fight Covid-19” today at 11:00 am Eastern Daylight Time

Neuronetics, Inc., a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Senior Vice President, Chief Financial Officer, and Treasurer will participate at the William Blair 41st Annual Growth Stock Conference.

Entera Bio Ltd., a leader in the development of orally delivered large molecule therapeutics, announced financial and operating results for the quarter ended March 31, 2021.

Pharmaceutical industry veteran brings more than 20 years of business and technical operations experience across various commercial and development products

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, Chief Executive Officer, and Andrew Schemick, Chief Financial Officer, will participate in the following virtual investor conferences: William Blair’s 41st Annual Growth Stock Conference Fireside Chat on Tuesday, June 1 st at 11:40 a.m. ET Jefferies Virtual Healthcare Conference Fireside Chat on Friday, June 4 th at 10:00 a.m. ET

New Executives Bring Decades of Healthcare Industry Experience and Knowledge of the Nitric Oxide Market to Beyond Air in Preparation for Launch of LungFit® PH in the US